SKYE LACEY: Open Payments
NPI 1669521647 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,191 in 62 payments from 13 companies in 2025. Trend: 2023 $1,194 · 2024 $881 · 2025 $1,191
Food & beverage: $1,191
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $519 |
| Novartis Pharmaceuticals Corporation | 10 | $174 |
| GENZYME CORPORATION | 1 | $94 |
| Janssen Biotech, Inc. | 2 | $93 |
| Amgen Inc. | 5 | $87 |
| Arcutis Biotherapeutics, Inc. | 2 | $39 |
| Botanix SB Inc | 2 | $37 |
| UCB, Inc. | 2 | $29 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $28 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $28 |
Products named: SKYRIZI, RINVOQ, COSENTYX, DUPIXENT, TREMFYA, OTEZLA, Rhapsido, Zoryve.
Industry payments across KS — which companies pay providers there.
